Header Logo

Brian Silver

Concepts (465)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
73
2021
1127
10.450
Why?
Ischemic Attack, Transient
14
2019
90
4.930
Why?
Brain Ischemia
26
2020
399
3.980
Why?
Fibrinolytic Agents
15
2020
163
2.350
Why?
Tissue Plasminogen Activator
16
2020
125
2.160
Why?
Thrombolytic Therapy
11
2020
184
1.560
Why?
Cerebral Hemorrhage
8
2021
85
1.490
Why?
Atrial Fibrillation
11
2020
805
1.400
Why?
Stroke Rehabilitation
5
2021
46
1.310
Why?
Brain
14
2024
1488
1.290
Why?
Humans
108
2025
59360
1.180
Why?
Secondary Prevention
4
2017
151
1.100
Why?
Middle Cerebral Artery
4
2017
46
1.090
Why?
Hypertension
8
2017
568
1.070
Why?
Aged
50
2021
13416
1.000
Why?
Thrombectomy
2
2019
208
0.990
Why?
Antihypertensive Agents
4
2016
162
0.940
Why?
Cell-Free Nucleic Acids
1
2024
11
0.910
Why?
Cerebrovascular Disorders
4
2018
74
0.900
Why?
Female
62
2021
30705
0.890
Why?
Organoids
1
2024
40
0.890
Why?
Platelet Aggregation Inhibitors
8
2014
211
0.870
Why?
Male
56
2021
27739
0.840
Why?
Motor Neuron Disease
1
2023
28
0.830
Why?
Hematoma
3
2019
68
0.800
Why?
Heart Septal Defects, Atrial
2
2016
8
0.790
Why?
Blood Pressure
3
2016
495
0.750
Why?
Middle Aged
46
2021
16317
0.740
Why?
Treatment Outcome
28
2020
5284
0.720
Why?
Endovascular Procedures
3
2016
608
0.710
Why?
Emergency Medical Services
2
2014
255
0.680
Why?
Aged, 80 and over
24
2021
5128
0.670
Why?
Bed Rest
1
2019
10
0.670
Why?
Myxoma
1
2019
13
0.660
Why?
Risk Factors
25
2020
4984
0.660
Why?
Tomography, X-Ray Computed
13
2016
1526
0.640
Why?
Severity of Illness Index
13
2019
1479
0.630
Why?
Time Factors
22
2020
3617
0.630
Why?
Retrospective Studies
22
2020
6071
0.630
Why?
Piperazines
3
2025
74
0.620
Why?
Telemedicine
2
2023
307
0.620
Why?
Carotid Stenosis
4
2014
104
0.610
Why?
Electrocardiography, Ambulatory
2
2017
40
0.600
Why?
Magnetic Resonance Imaging
13
2021
2060
0.590
Why?
Infarction, Middle Cerebral Artery
2
2017
70
0.580
Why?
Emergency Service, Hospital
2
2016
1021
0.560
Why?
Concurrent Review
1
2017
3
0.560
Why?
Length of Stay
4
2020
775
0.560
Why?
Triage
2
2016
109
0.550
Why?
Ticlopidine
2
2014
45
0.540
Why?
Endocarditis, Bacterial
1
2016
31
0.530
Why?
Teaching
2
2008
152
0.530
Why?
Virtual Reality
1
2016
12
0.520
Why?
Thalamic Diseases
1
2016
2
0.520
Why?
Primary Prevention
1
2017
134
0.510
Why?
Spondylitis, Ankylosing
1
2016
24
0.500
Why?
Aspirin
2
2014
166
0.500
Why?
Practice Patterns, Physicians'
2
2020
687
0.490
Why?
Postmenopause
4
2021
224
0.470
Why?
Quality of Health Care
2
2020
510
0.460
Why?
Feedback, Psychological
1
2014
11
0.460
Why?
Occupational Therapy
1
2014
12
0.450
Why?
Speech Therapy
1
2014
15
0.450
Why?
Physical Therapy Modalities
1
2014
45
0.440
Why?
Dipyridamole
1
2013
17
0.440
Why?
Smoking
4
2018
826
0.440
Why?
Anti-Bacterial Agents
2
2016
735
0.430
Why?
Endarterectomy, Carotid
2
2012
91
0.430
Why?
Spinocerebellar Ataxias
1
2013
10
0.430
Why?
Healthcare Disparities
3
2020
326
0.420
Why?
Interprofessional Relations
1
2014
129
0.420
Why?
Coronavirus Infections
3
2020
192
0.410
Why?
Pneumonia, Viral
3
2020
205
0.410
Why?
Dementia, Multi-Infarct
1
2012
4
0.410
Why?
Encephalitis, Varicella Zoster
1
2012
2
0.410
Why?
Quality Improvement
1
2017
416
0.400
Why?
Cocaine-Related Disorders
1
2013
82
0.400
Why?
Intracranial Aneurysm
1
2016
345
0.400
Why?
Diffusion Magnetic Resonance Imaging
7
2020
145
0.400
Why?
Intracranial Hemorrhages
3
2020
61
0.400
Why?
Sulfones
2
2009
36
0.390
Why?
Recovery of Function
7
2020
270
0.390
Why?
Hospital Units
1
2011
8
0.390
Why?
Cohort Studies
7
2019
2374
0.380
Why?
Leukoaraiosis
3
2019
44
0.380
Why?
Colonoscopy
1
2012
86
0.370
Why?
Brain Damage, Chronic
1
2011
5
0.370
Why?
Inpatients
1
2014
291
0.370
Why?
Hospitals
1
2014
375
0.360
Why?
Vertebrobasilar Insufficiency
2
2012
23
0.360
Why?
Stents
2
2013
461
0.350
Why?
Internship and Residency
2
2008
746
0.340
Why?
Educational Measurement
2
2008
211
0.320
Why?
Cerebral Cortex
1
2011
248
0.320
Why?
Neurology
3
2020
33
0.320
Why?
Troponin
2
2019
36
0.320
Why?
Anticoagulants
4
2019
477
0.320
Why?
Mortality
2
2021
155
0.310
Why?
Prognosis
7
2020
1600
0.310
Why?
Neurophysiology
1
2008
7
0.300
Why?
Clinical Medicine
1
2008
15
0.300
Why?
Video Games
1
2008
12
0.300
Why?
Embolism, Paradoxical
1
2008
13
0.300
Why?
Foramen Ovale, Patent
1
2008
13
0.290
Why?
Mass Screening
1
2013
645
0.290
Why?
Intracranial Embolism
3
2017
39
0.280
Why?
Young Adult
6
2019
4267
0.280
Why?
Recurrence
4
2016
603
0.280
Why?
Spinal Puncture
1
2007
15
0.270
Why?
Acute Disease
3
2014
660
0.270
Why?
Continuous Positive Airway Pressure
1
2007
30
0.270
Why?
Whole Genome Sequencing
2
2024
63
0.270
Why?
Brain Stem Infarctions
1
2006
4
0.260
Why?
Needles
1
2007
65
0.260
Why?
Pons
1
2006
15
0.260
Why?
Quadriplegia
1
2006
14
0.260
Why?
Smoking Cessation
3
2018
541
0.260
Why?
Sleep Apnea, Obstructive
1
2007
54
0.260
Why?
Magnetic Resonance Angiography
4
2016
178
0.260
Why?
Age Factors
6
2020
1504
0.250
Why?
Ventricular Function, Left
2
2018
257
0.250
Why?
Predictive Value of Tests
7
2020
1025
0.250
Why?
Ultrasonography, Doppler, Transcranial
2
2016
21
0.250
Why?
Piracetam
1
2005
8
0.250
Why?
Hyponatremia
1
2005
13
0.240
Why?
Logistic Models
7
2018
1232
0.240
Why?
Pandemics
4
2023
615
0.240
Why?
Hospitalization
4
2020
1290
0.240
Why?
Anticonvulsants
1
2005
88
0.230
Why?
Clinical Protocols
1
2005
135
0.230
Why?
Thalamus
2
2016
64
0.230
Why?
Curriculum
1
2008
558
0.220
Why?
Betacoronavirus
3
2020
166
0.220
Why?
Epilepsy
1
2005
105
0.220
Why?
Hypercholesterolemia
2
2014
68
0.220
Why?
Heart Atria
2
2017
135
0.210
Why?
Cerebral Angiography
4
2017
280
0.210
Why?
Neoplasm Proteins
1
2025
277
0.210
Why?
Adult
13
2019
15669
0.200
Why?
National Institute of Neurological Disorders and Stroke (U.S.)
2
2020
7
0.200
Why?
Ischemia
2
2019
199
0.200
Why?
Purpura, Thrombotic Thrombocytopenic
1
2022
8
0.200
Why?
Carotid Artery, Common
1
2002
30
0.190
Why?
United States
10
2020
7390
0.190
Why?
Health Services Needs and Demand
2
2020
203
0.190
Why?
Rehabilitation Centers
1
2021
12
0.190
Why?
Carotid Artery Diseases
1
2002
63
0.190
Why?
Venous Thromboembolism
2
2014
141
0.180
Why?
Eggs
1
2021
7
0.180
Why?
Multivariate Analysis
6
2018
902
0.180
Why?
Cerebral Amyloid Angiopathy
1
2021
3
0.180
Why?
Oxygen
2
2014
313
0.180
Why?
Genetic Loci
1
2021
107
0.180
Why?
Biomarkers
2
2024
1306
0.180
Why?
Cholesterol, Dietary
1
2021
28
0.180
Why?
Incidence
6
2020
1237
0.180
Why?
Clinical Trials as Topic
2
2016
441
0.180
Why?
Skilled Nursing Facilities
1
2021
83
0.180
Why?
Myocardial Infarction
3
2019
862
0.180
Why?
Risk Assessment
6
2020
1921
0.180
Why?
Precision Medicine
1
2021
102
0.170
Why?
Databases, Factual
4
2020
813
0.170
Why?
Noncommunicable Diseases
1
2020
15
0.170
Why?
Patient Discharge
2
2021
489
0.170
Why?
Drug Administration Schedule
2
2012
283
0.170
Why?
Time-to-Treatment
1
2020
98
0.170
Why?
Cost-Benefit Analysis
2
2011
297
0.170
Why?
Phosphodiesterase Inhibitors
3
2009
27
0.160
Why?
Thrombosis
1
2002
182
0.160
Why?
Retinal Artery Occlusion
1
2019
5
0.160
Why?
Cyclic GMP
3
2009
28
0.160
Why?
Vitamin K
1
2019
14
0.160
Why?
Heart Neoplasms
1
2019
31
0.160
Why?
Antineoplastic Agents
1
2025
631
0.160
Why?
Prospective Studies
7
2021
3067
0.160
Why?
Polymorphism, Single Nucleotide
1
2021
439
0.160
Why?
Global Health
1
2020
167
0.160
Why?
Drug Therapy, Combination
3
2012
452
0.160
Why?
Sweetening Agents
1
2019
21
0.160
Why?
Embolism
1
2019
39
0.160
Why?
Neurodegenerative Diseases
1
2021
134
0.160
Why?
Mechanical Thrombolysis
1
2019
35
0.160
Why?
Leukoencephalopathies
1
2019
24
0.150
Why?
Women's Health
2
2019
360
0.150
Why?
Sex Factors
3
2019
935
0.150
Why?
Spinal Cord
2
2016
195
0.150
Why?
Beverages
1
2019
66
0.150
Why?
Nervous System Diseases
1
2020
104
0.150
Why?
Sensitivity and Specificity
3
2019
1093
0.150
Why?
Sildenafil Citrate
2
2009
11
0.150
Why?
Activities of Daily Living
2
2019
289
0.150
Why?
Subarachnoid Hemorrhage
2
2016
93
0.150
Why?
Purines
2
2009
38
0.150
Why?
Genetic Predisposition to Disease
1
2021
676
0.150
Why?
Rhode Island
2
2016
97
0.140
Why?
Dose-Response Relationship, Drug
3
2009
806
0.140
Why?
White Matter
1
2019
114
0.140
Why?
Hypoalbuminemia
1
2017
7
0.140
Why?
Functional Laterality
2
2016
133
0.140
Why?
Radiography
2
2019
517
0.140
Why?
Weight Gain
1
2018
163
0.140
Why?
Demyelinating Diseases
1
1997
16
0.140
Why?
Vacuoles
1
1997
26
0.140
Why?
Atrial Function, Right
1
2017
1
0.140
Why?
Ventricular Dysfunction, Left
1
2018
158
0.140
Why?
Surveys and Questionnaires
2
2023
2513
0.140
Why?
Hospital Mortality
5
2020
841
0.140
Why?
Telemetry
1
2017
19
0.140
Why?
Systemic Inflammatory Response Syndrome
1
2017
41
0.140
Why?
Atrial Flutter
1
2017
21
0.140
Why?
Hospital Administration
1
2017
41
0.140
Why?
Cardiopulmonary Resuscitation
1
2018
85
0.140
Why?
Disability Evaluation
4
2019
199
0.140
Why?
Stroke Volume
1
2018
314
0.140
Why?
Headache Disorders, Primary
1
2016
4
0.130
Why?
Alcohol Abstinence
1
2016
10
0.130
Why?
Random Allocation
1
2017
192
0.130
Why?
Spinal Cord Diseases
1
1997
39
0.130
Why?
Vasospasm, Intracranial
1
2016
25
0.130
Why?
Brain Diseases
1
1997
71
0.130
Why?
Heart Diseases
1
2018
206
0.130
Why?
Motor Activity
1
2019
333
0.130
Why?
Breast Feeding
1
2018
143
0.130
Why?
Dura Mater
1
2016
33
0.130
Why?
Delivery of Health Care
1
2020
408
0.130
Why?
Systole
1
2016
109
0.130
Why?
Carbolines
2
2025
9
0.130
Why?
Heart Arrest
1
2018
161
0.130
Why?
Radiography, Thoracic
1
2016
110
0.120
Why?
User-Computer Interface
1
2016
123
0.120
Why?
Registries
5
2020
801
0.120
Why?
Heart Rate
1
2017
307
0.120
Why?
Cognition
1
2019
455
0.120
Why?
Aneurysm, Ruptured
1
2016
71
0.120
Why?
Radionuclide Imaging
1
2015
121
0.120
Why?
Cerebral Infarction
3
2016
76
0.120
Why?
Decompressive Craniectomy
1
2014
5
0.120
Why?
Brain Death
1
2014
16
0.120
Why?
Potassium, Dietary
1
2014
2
0.120
Why?
Cerebral Ventricles
1
2014
30
0.120
Why?
Hospitals, Urban
1
2014
43
0.120
Why?
Neoplasms
1
2025
1240
0.120
Why?
Skull
1
2014
50
0.120
Why?
Ultrasonography
2
2010
459
0.120
Why?
Odds Ratio
4
2017
745
0.120
Why?
Adolescent
3
2016
5824
0.120
Why?
Ambulatory Care
1
2017
300
0.120
Why?
Double-Blind Method
3
2020
715
0.110
Why?
Motion Therapy, Continuous Passive
1
2014
1
0.110
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2014
206
0.110
Why?
Hospital Departments
1
2014
12
0.110
Why?
Comorbidity
3
2020
1078
0.110
Why?
Health Literacy
1
2015
78
0.110
Why?
Immunoglobulin Fab Fragments
2
2004
36
0.110
Why?
Drainage
1
2014
149
0.110
Why?
Quality Indicators, Health Care
1
2017
332
0.110
Why?
Coloring Agents
1
2014
53
0.110
Why?
Diagnostic Errors
1
2014
95
0.110
Why?
Heart Failure
2
2018
853
0.110
Why?
Cardiovascular Diseases
1
2021
788
0.110
Why?
Alcoholism
1
2016
309
0.110
Why?
Risk Reduction Behavior
1
2014
121
0.110
Why?
Hyperglycemia
1
2014
98
0.110
Why?
Urinary Tract Infections
1
2014
80
0.110
Why?
Heparin
1
2014
111
0.110
Why?
Acute Coronary Syndrome
1
2016
250
0.100
Why?
Age of Onset
1
2013
170
0.100
Why?
Basal Ganglia Cerebrovascular Disease
1
2012
1
0.100
Why?
Pupil Disorders
1
2012
4
0.100
Why?
Dysarthria
1
2012
7
0.100
Why?
Apraxias
1
2012
7
0.100
Why?
Acyclovir
1
2012
19
0.100
Why?
Adrenal Cortex Hormones
1
2014
169
0.100
Why?
Academic Medical Centers
1
2014
306
0.100
Why?
Gait Disorders, Neurologic
1
2012
17
0.100
Why?
Valine
1
2012
31
0.100
Why?
Cyclophosphamide
1
2012
75
0.100
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2014
202
0.100
Why?
Prednisone
1
2012
85
0.100
Why?
Memory Disorders
1
2012
48
0.100
Why?
Risk
2
2010
364
0.100
Why?
Vision Disorders
1
2012
59
0.100
Why?
Disease Progression
2
2017
1122
0.100
Why?
Cerebral Arteries
2
2009
39
0.100
Why?
Infusions, Intravenous
3
2020
164
0.090
Why?
Diagnosis, Differential
2
2019
937
0.090
Why?
Retinal Vein
1
2011
5
0.090
Why?
Vision, Low
1
2011
9
0.090
Why?
Graves Disease
1
2010
15
0.090
Why?
Echocardiography
3
2018
457
0.090
Why?
Hospital Costs
1
2011
119
0.090
Why?
Retinal Vein Occlusion
1
2011
18
0.090
Why?
Moyamoya Disease
1
2010
10
0.090
Why?
Dyslipidemias
1
2010
33
0.090
Why?
Lameness, Animal
1
2010
9
0.090
Why?
Proportional Hazards Models
3
2018
674
0.090
Why?
Prevalence
2
2020
1252
0.090
Why?
Organ Size
1
2010
164
0.090
Why?
Horse Diseases
1
2010
22
0.090
Why?
Interrupted Time Series Analysis
2
2020
27
0.090
Why?
Disease Susceptibility
1
2010
157
0.090
Why?
HIV Infections
1
1997
913
0.080
Why?
Hemorrhage
1
2012
260
0.080
Why?
Health Knowledge, Attitudes, Practice
1
2015
724
0.080
Why?
Life Style
1
2011
299
0.080
Why?
Antibodies, Monoclonal
2
2004
839
0.080
Why?
Antiviral Agents
1
2012
313
0.080
Why?
Vasodilator Agents
1
2009
63
0.080
Why?
Lipoproteins, HDL
1
2009
35
0.080
Why?
Neovascularization, Physiologic
2
2006
101
0.080
Why?
Recombinant Proteins
4
2020
689
0.080
Why?
Venous Thrombosis
1
2009
110
0.070
Why?
Medical History Taking
1
2008
65
0.070
Why?
Physical Examination
1
2008
104
0.070
Why?
Host-Pathogen Interactions
2
2020
241
0.070
Why?
Drug-Related Side Effects and Adverse Reactions
1
2009
140
0.070
Why?
Snoring
1
2007
8
0.070
Why?
Sleep Stages
1
2007
16
0.070
Why?
Neuropharmacology
1
2007
1
0.070
Why?
Neuroanatomy
1
2007
3
0.070
Why?
Pulmonary Embolism
1
2009
170
0.070
Why?
Group Processes
1
2007
41
0.070
Why?
Europe
2
2017
184
0.070
Why?
Postoperative Period
1
2007
127
0.070
Why?
3',5'-Cyclic-GMP Phosphodiesterases
1
2006
4
0.070
Why?
Polysomnography
1
2007
55
0.070
Why?
Magnetoencephalography
1
2006
7
0.070
Why?
Evoked Potentials, Somatosensory
1
2006
8
0.070
Why?
Manipulation, Chiropractic
1
2006
5
0.070
Why?
Vertebral Artery Dissection
1
2006
14
0.070
Why?
Reproducibility of Results
3
2019
1561
0.060
Why?
Nerve Regeneration
1
2006
31
0.060
Why?
Stem Cell Transplantation
1
2006
75
0.060
Why?
Basilar Artery
1
2006
30
0.060
Why?
Diabetes Mellitus
1
2010
515
0.060
Why?
Postoperative Complications
1
2012
1202
0.060
Why?
Carbamazepine
1
2005
11
0.060
Why?
Inappropriate ADH Syndrome
1
2005
7
0.060
Why?
Canada
1
2005
147
0.060
Why?
Sodium
1
2005
60
0.060
Why?
Topotecan
1
2025
5
0.060
Why?
Neuronal Plasticity
1
2006
141
0.060
Why?
Program Evaluation
1
2007
470
0.060
Why?
Nitric Oxide Synthase Type II
1
2025
70
0.060
Why?
Doxorubicin
1
2025
97
0.060
Why?
Molecular Docking Simulation
1
2025
73
0.060
Why?
Patient Selection
3
2017
464
0.060
Why?
Cardiac Surgical Procedures
1
2007
249
0.050
Why?
Protein Structure, Tertiary
1
2025
657
0.050
Why?
Practice Guidelines as Topic
1
2007
705
0.050
Why?
Disintegrins
1
2022
4
0.050
Why?
ADAMTS13 Protein
1
2022
6
0.050
Why?
Thrombospondins
1
2022
6
0.050
Why?
Rural Health
1
2002
15
0.050
Why?
Subacute Care
1
2021
9
0.050
Why?
Pilot Projects
2
2021
914
0.050
Why?
Delphi Technique
1
2021
77
0.050
Why?
Disabled Persons
1
2003
187
0.040
Why?
Iran
1
2020
6
0.040
Why?
Cell Line, Tumor
1
2025
1370
0.040
Why?
Immunohistochemistry
2
2006
847
0.040
Why?
Hospital Bed Capacity
1
2020
25
0.040
Why?
Retina
1
2021
115
0.040
Why?
Placebo Effect
1
2020
10
0.040
Why?
Bayes Theorem
1
2020
109
0.040
Why?
Health Care Rationing
1
2020
21
0.040
Why?
Ethics, Medical
1
2020
37
0.040
Why?
Genome-Wide Association Study
1
2021
331
0.040
Why?
Health Resources
1
2020
87
0.040
Why?
Cause of Death
1
2020
210
0.040
Why?
Infection Control
1
2020
94
0.040
Why?
Cost of Illness
1
2020
156
0.040
Why?
Needs Assessment
1
2020
187
0.040
Why?
Angiography
1
2019
146
0.040
Why?
Feeding Behavior
1
2021
254
0.040
Why?
Neurologic Examination
1
2019
52
0.040
Why?
Cerebral Small Vessel Diseases
1
2018
7
0.040
Why?
Health Status Disparities
1
2020
137
0.040
Why?
Arterial Occlusive Diseases
1
2019
71
0.040
Why?
Sex Distribution
1
2019
244
0.040
Why?
Age Distribution
1
2019
249
0.040
Why?
Administration, Oral
1
2019
356
0.040
Why?
Argentina
1
2017
7
0.040
Why?
North America
1
2017
106
0.040
Why?
Venules
1
1997
8
0.040
Why?
Patient Admission
1
2019
184
0.040
Why?
Italy
1
2017
63
0.030
Why?
Biomedical Research
1
2020
256
0.030
Why?
Serum Albumin
1
2017
45
0.030
Why?
Latin America
1
2017
12
0.030
Why?
Neuropsychological Tests
1
2019
371
0.030
Why?
Glasgow Coma Scale
1
2017
43
0.030
Why?
Algorithms
2
2016
976
0.030
Why?
Disease Management
1
2018
221
0.030
Why?
Chi-Square Distribution
1
2017
409
0.030
Why?
Socioeconomic Factors
1
2019
741
0.030
Why?
Tomography Scanners, X-Ray Computed
1
2016
13
0.030
Why?
Intensive Care Units
1
2020
423
0.030
Why?
Clinical Decision-Making
1
2017
146
0.030
Why?
Non-ST Elevated Myocardial Infarction
1
2016
30
0.030
Why?
Angina, Unstable
1
2016
56
0.030
Why?
Embolectomy
1
2016
15
0.030
Why?
Follow-Up Studies
3
2009
2337
0.030
Why?
Rats, Wistar
2
2006
179
0.030
Why?
Survival Rate
1
2018
802
0.030
Why?
Research Design
1
2019
555
0.030
Why?
Observer Variation
2
2006
205
0.030
Why?
Health Services Accessibility
1
2020
521
0.030
Why?
Longitudinal Studies
1
2019
1189
0.030
Why?
Kaplan-Meier Estimate
1
2016
396
0.030
Why?
ST Elevation Myocardial Infarction
1
2016
73
0.030
Why?
Body Mass Index
1
2019
831
0.030
Why?
Renal Insufficiency, Chronic
1
2016
114
0.030
Why?
Massachusetts
1
2020
2002
0.030
Why?
Information Dissemination
1
2015
111
0.030
Why?
Critical Illness
1
2017
325
0.030
Why?
Health Education
1
2015
182
0.030
Why?
Brain Injuries
1
2014
135
0.030
Why?
Rats
2
2006
1910
0.030
Why?
Pupil
1
2011
9
0.020
Why?
Paresis
1
2010
15
0.020
Why?
Confusion
1
2010
16
0.020
Why?
Plasmapheresis
1
2010
18
0.020
Why?
Antithyroid Agents
1
2010
18
0.020
Why?
Toe Phalanges
1
2010
3
0.020
Why?
Thyroidectomy
1
2010
31
0.020
Why?
Ligaments
1
2010
11
0.020
Why?
Tendons
1
2010
23
0.020
Why?
Horses
1
2010
52
0.020
Why?
Bone Marrow
1
2010
177
0.020
Why?
Glucocorticoids
1
2010
179
0.020
Why?
Cross-Sectional Studies
1
2015
2373
0.020
Why?
Multicenter Studies as Topic
1
2008
130
0.020
Why?
Regression Analysis
1
2009
485
0.020
Why?
Tadalafil
1
2006
2
0.020
Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
1
2006
6
0.020
Why?
Ferrocyanides
1
2006
1
0.020
Why?
Anisotropy
1
2006
58
0.020
Why?
Nerve Fibers
1
2006
29
0.020
Why?
Microcirculation
1
2006
52
0.020
Why?
Isoenzymes
1
2006
136
0.020
Why?
Multiple Myeloma
1
2011
325
0.020
Why?
Cyclic AMP
1
2006
142
0.020
Why?
Early Diagnosis
1
2006
92
0.020
Why?
Animals
3
2010
19651
0.020
Why?
Axons
1
2006
118
0.020
Why?
Placebos
1
2005
68
0.020
Why?
Data Interpretation, Statistical
1
2006
191
0.020
Why?
Endothelial Cells
1
2006
173
0.010
Why?
Behavior, Animal
1
2006
215
0.010
Why?
Randomized Controlled Trials as Topic
1
2008
677
0.010
Why?
Decision Making
1
2008
395
0.010
Why?
Stem Cells
1
2006
255
0.010
Why?
Nervous System
1
2004
69
0.010
Why?
Models, Statistical
1
2005
298
0.010
Why?
Image Processing, Computer-Assisted
1
2006
654
0.010
Why?
Cell Proliferation
1
2006
942
0.010
Why?
Blood Glucose
1
2004
461
0.010
Why?
Ontario
1
2002
43
0.010
Why?
Injections, Intravenous
1
2002
155
0.010
Why?
National Institutes of Health (U.S.)
1
2002
111
0.010
Why?
Transportation of Patients
1
2002
42
0.010
Why?
Linear Models
1
2002
402
0.010
Why?
Neurons
1
2006
863
0.010
Why?
Disease Models, Animal
1
2006
2050
0.010
Why?
Silver's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (465)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_